Volume 26 Issue 3
Jun.  2002
Article Contents

Citation:

Radioactive seed implantation treatment for prostate carcinoma

  • Received Date: 2002-03-09
  • There are total 20 years for radioactive seed implantation treatment for prostate carcinoma, especiately recent 5 years. Ultrosound or CT guidance plus computer treatment planning system make the seed implantation become more effective, minidamage and low risk of complications, it become more and more popular in clinical treatment for cancer patients.
  • 加载中
  • [1] Vicini FA,Horwitz EM,Gonzalez J. Treatment options for localized prostate cancer based upon pretreatment prostate specific antigen levels[J].Journal of Urology,1997,(2):319-325.
    [2] Vicini FA,Horwitz EM,Kini VR. Radiotherapy options for localized prostate cancer based upon pretreatment serum prostate specific antigen levels and biochemical control:A comprehensive review of the literature[J].International Journal of Radiation Oncology,Biology,Physics,1998.1101-1110.
    [3] Horwitz EM,Vicini FA,Ziaja EL. Assessing the variability of outcome for patients treated with localized prostate irradiation using different definitions of bioeheroieal control[J].International Journal of Radiation Oncology,Biology,Physics,1996.565-575.
    [4] Hilaris RS. Brachytherapy in cancer of the prostate:an historical perspective[J].Seminars in Surgical Oncology,1997.399-405.
    [5] Vicini FA,Kini VR,Edmundson G. A comprehensive review of prostate cancer brachytherapy:difining an optimal technique[J].International Journal of Radiation Oncology,Biology,Physics,1999,(3):483-491.
    [6] Blasko JC,Wallner K,Grimm PD. Prostate specific antigen based disease control following ultrasound guided 125-iodine implantation for stage T1/T2 prostatic carcinoma[J].Journal of Urology,1995.1096-1099.
    [7] Mate TP,Gottesman JE,Hatton J. High dose-rate afterloading 192-iridium prostate brachytherapy:Feasibility report[J].International Journal of Radiation Oncology,Biology,Physics,1998.525-533.
    [8] Wallner K,Roy J,Harrison L. Tumor control and morbidity following transperineal iodine 125 implantation for stage T1/T2 prostatic carcinoma[J].Journal of Clinical Oncology,1996.449-453.
    [9] Prestige BR,Bite WS,Kiefer EJ. Timing of computerd tomography-based postimplant assessment following permanent transperineal prostate brachytherspy[J].International Journal of Radiation Oncology,Biology,Physics,1998.1111-1115.
    [10] Blasko JC,Radge H,Grim PD. Transperineal ultrosoundguided implantation of the prostate:mobidity and complication[J].Scandinavian Journal of Urology and Nephrology,1991.113-118.
    [11] Nori D,Moni FJ. Current issues in techniques of prostate brachytherapy[J].Seminars in Surgical Oncology,1997.444-453.
    [12] Parker SL,Tong T,Bolden S. Cancer statistics,1997[J].Ca Journal of Clin,1997.5-27.
  • 加载中
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索

Article Metrics

Article views(1093) PDF downloads(2) Cited by()

Related
Proportional views

Radioactive seed implantation treatment for prostate carcinoma

  • Department of Radiation Oncology, Peking University 3 rd Hospital, Beijing 100034, China

Abstract: There are total 20 years for radioactive seed implantation treatment for prostate carcinoma, especiately recent 5 years. Ultrosound or CT guidance plus computer treatment planning system make the seed implantation become more effective, minidamage and low risk of complications, it become more and more popular in clinical treatment for cancer patients.

    HTML

Reference (12)

Catalog

/

DownLoad:  Full-Size Img  PowerPoint
Return
Return